In This Section

Government Relations

ACNM Government Relations Areas of Focus

  • Representation of nuclear physician's interests before Congress and federal regulatory bodies
  • Monthly government affairs reports
  • Electronic issue alerts
  • FDA activities with respect to review and approval of radiopharmaceuticals
  • NRC quality assurance activities
  • Efforts to influence federal funding for nuclear medicine research
  • Educational and training requirements for NRC licensure
  • Nuclear medicine political action committee

Breaking News

ACNM relays concern about Executive Order 13769, suspending the entry of alien nationals from seven countries, to the US President.  Read ACNM's letter to the president.

ACNM responds to the US Nuclear Regulatory Commission Draft Program-Specific Guidance About Medical Use Licenses (NRC-2016-0122), questioning the utility of the proposed revision.  Read ACNM's response.

Latest News

  • June 12, 2018The AMA's RUC and Why It Is Important to You
    The American Medical Association (AMA) has an expert panel called the Relative Value Scale Update Committee (RUC), which advocates for accurate valuation of all physician services. If you receive a request from SNMMI to participate in an AMA RUC survey, it is imperative that you participate so your voice can be heard.
  • May 29, 2018Comments Sent to FDA Regarding Amino Acids Needed During Lu-177 DOTATATE Therapy
    SNMMI, the Mayo Clinic, Washington University School of Medicine in St. Louis, and Memorial Sloan Kettering Cancer Center have jointly filed comments with the FDA with recommendations for regulatory changes that would make it easier for patients with GEP-NETs to obtain arginine and lysine--amino acids that can mitigate side effects of Lu-177 DOTATATE therapy.
  • May 21, 2018SNMMI Advocates for Improved Reimbursement at CMS Public Meeting
    SNMMI recently advocated on behalf of members and their patients at the Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) workgroup public meeting. Lu-177-dotatate, Ga-68-dotatate, and Fl-18-fluciclovine are all delivered by pharmacies in per-study doses, not per-unit doses; SNMMI requested that CMS modify the coding descriptors for payment accordingly.
  • May 4, 2018FDA Issues Updated Guidance on Clinical Trial Imaging Standards
    The U.S. Food and Drug Administration (FDA) has issued an updated guidance for the standardization of imaging data collected and managed as part of clinical trials. While considerable standardization already exists in clinical imaging, the new guidance recommends additional trial-specific imaging process standards.
  • April 25, 2018eviCore Adds Coverage for Thyroid Imaging, Cites SNMMI Guideline
    eviCore has updated its coding recommendations for whole-body thyroid imaging.
  • View All Government Relations News »